Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

LDL apheresis lowers inflammation and cardiovascular risk by reducing CRP levels long-term.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Dexpanthenol helps protect the heart from damage by reducing inflammation and stress.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

HMG-CoA reductase is crucial for skin wound healing by regulating keratinocyte growth and blood vessel formation.

Inhibiting the PI3K/Akt pathway may help prevent radiation-induced liver injury.

Spironolactone can reduce hair growth in women with hirsutism.

Curcumin and its derivatives can block an enzyme important for making testosterone, with one derivative being particularly strong.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

Orlistat might block the body's ability to absorb thyroid medication.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

RNase L hinders hair growth by altering immune signals.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Spironolactone was effective in reducing hair growth in women with hirsutism.